Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Cross

Showing results (291-300 of 313) with videos related to

Pageof 32
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 7, 2021
Minimally invasive surgery for neuroblastic tumours: A SIOPEN multicentre study: Proposal for guidelinesH O Gabra, S Irtan, K Cross, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 15, 2024
Humoral immune response and safety of SARS-CoV-2 vaccination in very early onset inflammatory bowel diseaseArthur J Kastl, Kimberly N Weaver, Xian Zhang, et al.
The American Journal of Gastroenterology|January 14, 2022
Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel DiseasesMichael D Kappelman, Kimberly N Weaver, Xian Zhang, et al.
Environment & Health (Washington, D.C.)|May 21, 2026
Communicating Confidence in the Reliability of Micro- and Nanoplastic Identification in Human Health StudiesKevin V Thomas, Susanne Belz, Andy M Booth, et al.
Alimentary Pharmacology & Therapeutics|March 12, 2022
A United States expert consensus to standardise definitions, follow-up, and treatment targets for extra-intestinal manifestations in inflammatory bowel diseaseKatherine Falloon, Benjamin Cohen, Ashwin N Ananthakrishnan, et al.
Inflammatory Bowel Diseases|October 16, 2024
Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel DiseaseArthur J Kastl, Erica J Brenner, Kimberly N Weaver, et al.
Gastroenterology|July 3, 2018
Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative ColitisHans Herfarth, Edward L Barnes, John F Valentine, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2024
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel DiseaseErica J Brenner, Kimberly N Weaver, Xian Zhang, et al.
The American Journal of Gastroenterology|September 17, 2022
Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel DiseaseArthur J Kastl, Kimberly N Weaver, Xian Zhang, et al.
Inflammatory Bowel Diseases|December 23, 2017
IBD Serology and Disease Outcomes in African Americans With Crohn's DiseaseMadeline Bertha, Arthi Vasantharoopan, Archana Kumar, et al.
Pageof 32

Showing results (291-300 of 313) with videos related to

Sort By:
Pageof 32
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 7, 2021
Minimally invasive surgery for neuroblastic tumours: A SIOPEN multicentre study: Proposal for guidelinesH O Gabra, S Irtan, K Cross, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 15, 2024
Humoral immune response and safety of SARS-CoV-2 vaccination in very early onset inflammatory bowel diseaseArthur J Kastl, Kimberly N Weaver, Xian Zhang, et al.
The American Journal of Gastroenterology|January 14, 2022
Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel DiseasesMichael D Kappelman, Kimberly N Weaver, Xian Zhang, et al.
Environment & Health (Washington, D.C.)|May 21, 2026
Communicating Confidence in the Reliability of Micro- and Nanoplastic Identification in Human Health StudiesKevin V Thomas, Susanne Belz, Andy M Booth, et al.
Alimentary Pharmacology & Therapeutics|March 12, 2022
A United States expert consensus to standardise definitions, follow-up, and treatment targets for extra-intestinal manifestations in inflammatory bowel diseaseKatherine Falloon, Benjamin Cohen, Ashwin N Ananthakrishnan, et al.
Inflammatory Bowel Diseases|October 16, 2024
Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel DiseaseArthur J Kastl, Erica J Brenner, Kimberly N Weaver, et al.
Gastroenterology|July 3, 2018
Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative ColitisHans Herfarth, Edward L Barnes, John F Valentine, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2024
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel DiseaseErica J Brenner, Kimberly N Weaver, Xian Zhang, et al.
The American Journal of Gastroenterology|September 17, 2022
Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel DiseaseArthur J Kastl, Kimberly N Weaver, Xian Zhang, et al.
Inflammatory Bowel Diseases|December 23, 2017
IBD Serology and Disease Outcomes in African Americans With Crohn's DiseaseMadeline Bertha, Arthi Vasantharoopan, Archana Kumar, et al.
Pageof 32